Multiple Manufacturers

DACOGEN

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Dacogen HCPCS:

J0894

HCPCS Code Descriptor:

Injection, decitabine, 1 mg

Category:

J Code

Dacogen NDCs:

55111-0556-10, 70121-1644-01, 43598-0427-37, 43598-0348-37, 68001-0573-41, 63323-0825-20, 50742-0430-01, 67457-0316-25, 55150-0376-01, 75834-0190-01, 70860-0219-20, 72205-0031-01, 72205-0036-01, 16729-0224-05, 25021-0231-20, 71288-0119-20, 59148-0046-70, 00143-9385-01, 72603-0107-01, 16714-0928-01, 00781-3139-80, 68001-0618-37, 25021-0219-20, 69097-0905-67

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Dacogen CPT Codes:

Potential CPT administration codes for Dacogen can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

75834-0190-01, 70860-0219-20, 16729-0224-05, 59148-0046-70, 16714-0928-01, 00781-3139-80

About Dacogen:

DACOGEN is a medication manufactured by multiple manufacturers and aligned to the J Code: J0894. DACOGEN is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0894 Added Date:

January 1, 2007

J0894 Effective Date:

January 1, 2023

J0894 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Dacogen billing and coding information.
Our team did not identify a source for Dacogen patient assistance information. Please reach out to our team if you feel that this is a mistake.
DACOGEN prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for DACOGEN. Please check back in a few weeks.